rAAVen Therapeutics
At rAAVen Therapeutics, we unite rigorous science and curiosity-driven research to advance the next generation of gene therapies. With deep expertise in AAV biology, we design and engineer novel capsids for disorders across many tissues and organs. Using state-of-the-art molecular cloning, high-throughput AAV variant production, and next-generation sequencing, we build viral vectors optimized for precise delivery to defined cell populations and tailored functional performance for broad utility.